1. Home
  2. OXSQ vs NRXP Comparison

OXSQ vs NRXP Comparison

Compare OXSQ & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oxford Square Capital Corp.

OXSQ

Oxford Square Capital Corp.

HOLD

Current Price

$1.35

Market Cap

164.9M

Sector

Finance

ML Signal

HOLD

Logo NRX Pharmaceuticals Inc.

NRXP

NRX Pharmaceuticals Inc.

HOLD

Current Price

$3.49

Market Cap

153.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OXSQ
NRXP
Founded
2003
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.9M
153.2M
IPO Year
2003
2017

Fundamental Metrics

Financial Performance
Metric
OXSQ
NRXP
Price
$1.35
$3.49
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$38.25
AVG Volume (30 Days)
1.5M
991.4K
Earning Date
04-29-2026
05-14-2026
Dividend Yield
22.83%
N/A
EPS Growth
N/A
69.70
EPS
0.10
N/A
Revenue
N/A
$1,225,000.00
Revenue This Year
$3.61
$2,547.84
Revenue Next Year
N/A
$1,591.73
P/E Ratio
$13.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.05
$1.65
52 Week High
$2.21
$5.06

Technical Indicators

Market Signals
Indicator
OXSQ
NRXP
Relative Strength Index (RSI) 39.85 47.48
Support Level $1.29 $3.09
Resistance Level $1.43 $3.62
Average True Range (ATR) 0.04 0.21
MACD -0.01 0.02
Stochastic Oscillator 32.14 58.35

Price Performance

Historical Comparison
OXSQ
NRXP

About OXSQ Oxford Square Capital Corp.

Oxford Square Capital Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize portfolio's total return. Its primary current focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and, to a lesser extent collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. CLO investments may also include warehouse facilities, which are early-stage CLO vehicles intended to aggregate loans that may be used to form the basis of a traditional CLO vehicle. The company may also invest in publicly traded debt and/or equity securities.

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Share on Social Networks: